Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

SHA:600521 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,262	1,537	1,342	1,365	1,876	2,212
Trading Asset Securities	92.1	60.79	93.04	143.07	1.01	-
Cash & Short-Term Investments	2,354	1,597	1,435	1,508	1,877	2,212
Cash Growth	-18.75%	11.28%	-4.82%	-19.66%	-15.13%	46.83%
Accounts Receivable	3,375	3,235	2,557	2,831	1,906	1,757
Other Receivables	35.35	38.76	28.4	47.43	40.85	39.85
Receivables	3,410	3,274	2,585	2,879	1,947	1,797
Inventory	3,484	3,413	3,432	3,375	2,739	2,368
Prepaid Expenses	-	5.11	4.25	-	-	0
Other Current Assets	214.91	193.06	164.61	145.35	250.18	145.84
Total Current Assets	9,462	8,483	7,622	7,907	6,813	6,523
Property, Plant & Equipment	8,800	8,571	7,994	7,307	5,961	4,366
Long-Term Investments	816.73	796.17	785.25	863.17	1,027	641.78
Goodwill	64.45	64.45	64.45	70.9	70.9	70.9
Other Intangible Assets	1,185	1,196	1,113	1,072	970.6	806.93
Long-Term Deferred Tax Assets	190.6	189.67	171.99	183.9	110.15	175.73
Long-Term Deferred Charges	977.33	960.16	843.04	737.88	508.28	387.7
Other Long-Term Assets	1.05	1.09	6.45	9.46	7.87	18.51
Total Assets	21,497	20,261	18,600	18,152	15,468	12,991
Accounts Payable	1,642	1,585	1,387	1,203	881.79	894.34
Accrued Expenses	186.1	997.44	735.43	898.42	791.6	471.8
Short-Term Debt	2,210	2,110	1,583	1,397	1,314	1,005
Current Portion of Long-Term Debt	795.38	943.47	1,191	630.76	630.99	123.83
Current Portion of Leases	-	14.11	16.82	16.72	13.82	-
Current Income Taxes Payable	99.64	81.68	91.14	264.11	187.9	165.71
Current Unearned Revenue	46.27	54.4	33.51	67.7	66.71	40.09
Other Current Liabilities	866.42	189.5	407.71	321.64	348.93	190.42
Total Current Liabilities	5,846	5,976	5,445	4,799	4,236	2,891
Long-Term Debt	4,686	4,394	4,022	4,678	3,498	2,921
Long-Term Leases	27.7	16.99	44.93	59.14	66.41	-
Long-Term Unearned Revenue	682.33	698.95	665.44	532.09	448.44	299.36
Other Long-Term Liabilities	353.48	155.9	171.02	338	443.51	155.3
Total Liabilities	11,595	11,241	10,349	10,406	8,692	6,267
Common Stock	1,508	1,467	1,483	1,483	1,492	1,455
Additional Paid-In Capital	1,728	1,185	1,296	1,322	1,381	1,040
Retained Earnings	6,599	6,301	5,470	4,992	3,971	3,774
Treasury Stock	-300.05	-300.05	-416.91	-484.25	-521.84	-
Comprehensive Income & Other	245.29	244.47	244.43	233.98	236.54	243.73
Total Common Equity	9,779	8,898	8,077	7,547	6,559	6,513
Minority Interest	123.38	122.25	174.26	199.07	217.48	211.14
Shareholders' Equity	9,903	9,020	8,251	7,746	6,776	6,724
Total Liabilities & Equity	21,497	20,261	18,600	18,152	15,468	12,991
Total Debt	7,719	7,478	6,858	6,782	5,523	4,050
Net Cash (Debt)	-5,365	-5,881	-5,422	-5,273	-3,646	-1,838
Net Cash Per Share	-3.71	-4.06	-3.72	-3.61	-2.54	-1.26
Filing Date Shares Outstanding	1,490	1,449	1,468	1,473	1,484	1,455
Total Common Shares Outstanding	1,490	1,449	1,468	1,473	1,484	1,455
Working Capital	3,617	2,507	2,176	3,109	2,577	3,632
Book Value Per Share	6.40	5.97	5.34	4.96	4.26	4.31
Tangible Book Value	8,529	7,637	6,899	6,403	5,517	5,635
Tangible Book Value Per Share	5.56	5.10	4.54	4.18	3.56	3.71
Buildings	-	4,527	3,757	2,839	2,151	-
Machinery	-	6,228	5,546	152.08	3,827	-
Construction In Progress	-	2,188	2,317	2,803	2,502	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.